Plain-English translation of NCT04567056 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers have discovered that head and neck cancer shows specific patterns in how DNA is chemically marked (called methylation patterns). This study aims to confirm those findings in a larger group of patients. By comparing people with head and neck cancer to people without cancer, scientists hope to validate these DNA patterns as a way to better identify and understand the disease.
Early research found unique DNA patterns in head and neck cancer patients, but it needs to be tested in a larger group to confirm it's real and useful. This larger study will help doctors develop better tools to detect and understand this type of cancer.
You likely qualify if…
You likely don't qualify if…
If you have head and neck cancer, you would provide a tissue sample (likely collected during a procedure you may already be having). If you are in the control group with no cancer history, you would have a normal ear, nose, and throat examination and may also provide a tissue sample. The study is enrolling 300 people total and is currently recruiting participants.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Denmark
Enrollment target
~300 participants
Started
September 2020
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Christian Danstrup, M.D.
Department of Otolaryngology - Head and Neck Surgery, Aalborg University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.